(Q40464187)

20 September 2017

1 reference

title

Gene therapy for the vulnerable plaque (English)

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

8 July 2024

1

L. J. Feldman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642878

8 July 2024

author name string

J. M. Isner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642878

8 July 2024

language of work or name

English

0 references

publication date

1 September 1995

1 reference

full work available at URL

20 September 2017

https://doi.org/10.1016/0735-1097(95)00235-v

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642878

https://api.elsevier.com/content/article/PII:073510979500235V?httpAccept=text/xml

8 July 2024

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

https://api.elsevier.com/content/article/PII:073510979500235V?httpAccept=text/plain

8 July 2024

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Journal of the American College of Cardiology

8 July 2024

published in

1 reference

20 September 2017

volume

26

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

826-835

1 reference

Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques

20 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

8 July 2024

Why do plaques rupture?

2

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Atherosclerotic plaque caps are locally weakened when macrophages density is increased

8 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

8 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

The pathogenesis of atherosclerosis: a perspective for the 1990s

8 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Toward the quiescent coronary plaque

8 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Progression of coronary atherosclerosis: is coronary spasm related to progression?

8 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

8 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Inflammation and coronary artery disease

8 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture

8 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

8 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

8 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

8 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

8 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

8 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

8 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

8 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Coronary atherosclerosis. A multifactorial disease

8 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

A receptor-mediated pathway for cholesterol homeostasis

8 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia

8 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia

8 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

The advent of adenovirus. Gene therapy for cardiovascular disease

8 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes

8 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Long-Term Improvement of Hypercholesterolemia After Ex Vivo Gene Therapy in LDLR-Deficient Rabbits

8 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Ex vivo gene therapy of familial hypercholesterolemia.

8 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia

8 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Gene therapy for cholesterol

8 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Retroviral vector-mediated in vivo expression of low-density-lipoprotein receptors in the Watanabe heritable hyperlipidemic rabbit

8 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

8 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice

8 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery

8 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

8 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis.

8 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

8 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study

8 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

8 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

8 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit

8 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.

8 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice

8 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.

8 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits

8 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits

8 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-I into normal mice increases circulating high-density lipoprotein cholesterol

8 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

8 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina

8 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Are we mortgaging the medical profession?

8 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts

8 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

The L-arginine-nitric oxide pathway

8 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene

8 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Coronary arteriographic findings soon after non-Q-wave myocardial infarction

8 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

8 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion

8 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Final report on the aspirin component of the ongoing Physicians' Health Study

8 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group

8 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Prospects for site-specific delivery of pharmacologic and molecular therapies

8 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Tissue plasminogen activator

8 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Recombinant gene expression in vivo within endothelial cells of the arterial wall

8 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group

8 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Implantation of vascular grafts lined with genetically modified endothelial cells

8 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Intracoronary stents. A breakthrough technology or just another small step?

8 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Seeding of intravascular stents with genetically engineered endothelial cells

8 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro

8 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Coronary bypass graft fate: long-term angiographic study.

8 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Site-specific gene expression in vivo by direct gene transfer into the arterial wall

8 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog.

8 July 2024

83

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Prior arterial injury enhances luciferase expression following in vivo gene transfer

8 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors

8 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Efficient and selective adenovirus-mediated gene transfer into vascular neointima

8 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries

8 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Genetic modification of the vessel wall. Comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus

8 July 2024

88

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector

8 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit

8 July 2024

91

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries

8 July 2024

92

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury

8 July 2024

93

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter

8 July 2024

94

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon

8 July 2024

95

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Control of clot lysis by gene transfer

8 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Gene therapy for vascular smooth muscle cell proliferation after arterial injury

8 July 2024

98

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis

8 July 2024

99

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Catheter-mediated pulmonary vascular gene transfer and expression

8 July 2024

101

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene

8 July 2024

102

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

8 July 2024

103

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery

8 July 2024

106

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells

8 July 2024

107

1 reference

https://api.crossref.org/works/10.1016/0735-1097(95)00235-V

8 July 2024

Identifiers

1 reference

20 September 2017

1 reference